share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:擬議出售證券
美股SEC公告 ·  11/23 05:36

Moomoo AI 已提取核心訊息

Arcutis Biotherapeutics Officer Burnett Patrick plans to sell 16,023 common shares on 11/22/2024. The shares were acquired through a stock option exercise on 01/12/2024, with a total market value of approximately $162,515. The transaction will be completed with a cash payment.In the past 3 months, Arcutis Biotherapeutics has seen significant stock activity, with a total of 84,667 shares sold, generating gross proceeds of $846,243. Notable transactions include sales on 11/04/2024 and 11/14/2024, with the latter date seeing two separate transactions totaling 69,126 shares.This announcement provides investors with insight into the ongoing stock transactions by company insiders, reflecting potential strategic financial decisions.
Arcutis Biotherapeutics Officer Burnett Patrick plans to sell 16,023 common shares on 11/22/2024. The shares were acquired through a stock option exercise on 01/12/2024, with a total market value of approximately $162,515. The transaction will be completed with a cash payment.In the past 3 months, Arcutis Biotherapeutics has seen significant stock activity, with a total of 84,667 shares sold, generating gross proceeds of $846,243. Notable transactions include sales on 11/04/2024 and 11/14/2024, with the latter date seeing two separate transactions totaling 69,126 shares.This announcement provides investors with insight into the ongoing stock transactions by company insiders, reflecting potential strategic financial decisions.
Arcutis Biotherapeutics官員伯內特·帕特里克計劃於2024年11月22日出售16,023股普通股。這些股票於2024年12月1日通過股票期權行使收購,總市值約爲162,515美元。交易將以現金付款完成。在過去的3個月中,Arcutis Biotherapeutics出現了大量的股票活動,共售出84,667股股票,總收益爲846,243美元。值得注意的交易包括2024年4月11日和2024年11月14日的銷售,後一天的兩筆單獨交易共計69,126股。該公告使投資者能夠深入了解公司內部人士正在進行的股票交易,反映了潛在的戰略財務決策。
Arcutis Biotherapeutics官員伯內特·帕特里克計劃於2024年11月22日出售16,023股普通股。這些股票於2024年12月1日通過股票期權行使收購,總市值約爲162,515美元。交易將以現金付款完成。在過去的3個月中,Arcutis Biotherapeutics出現了大量的股票活動,共售出84,667股股票,總收益爲846,243美元。值得注意的交易包括2024年4月11日和2024年11月14日的銷售,後一天的兩筆單獨交易共計69,126股。該公告使投資者能夠深入了解公司內部人士正在進行的股票交易,反映了潛在的戰略財務決策。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息